Research Projects & Grants

Federal

• Zoster eye disease study (ZEDS): A multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthamicus (HZO) in the year prior to enrollment. (Protocol# 16-00463), Role: Investigator, National Eye Institute/NIH/DHHS, (03/2018 - 07/2024) Status: Completed

For Profit Organization

• A PHASE 3, MULTI-CENTER, RANDOMIZED, PARALLEL, DOUBLE MASKED, PLACEBO-CONTROLLED CLINICAL STUDY TO ASSESS THE SAFETY AND EFFICACY OF 0.1 % RGN-259 OPHTHALMIC SOLUTION FOR THE TREATMENT OF NEUROTROPHIC KERATOPATHY (SEER-2), Role: PI, ReGen Tree, LLC, (08/2024 - 08/2025) Status: Approved
• Study to Evaluate the Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants with Persistent Corneal Epithelial Defect (PCED), Role: PI, Combangio, Inc., (03/2025 - 03/2026) Status: Approved
• CSB-C20-003: A Multi-Center. Randomized, Double-Masked, Vehicle-Controlled. Parallel-Group. Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1 % in stage 2 and 3 Neurotrophic Keratitis Subjects, Role: PI, Claris Biotherapeutics, (11/2023 - 09/2024) Status: Completed

Internal

• Retrospective Analysis of Incidence, Prevalence, and Treatment Modalities of Neurotrophic Keratitis Post-Retinal Procedures, Role: Investigator, LLU Dept. of Ophthalmology, (08/2023) Status: Approved
• The effects of call on dry eye symptoms as measured by the Schirmer Test, Role: PI, LLU Dept. of Ophthalmology, (07/2013 - 07/2014) Status: Completed